January 2022 Issue Table Of Contents

From The Editor

• Lessons In Leaders Showing Up

Feature Articles

• Will Pyxis Oncology Be Pfizer’s Fourth Billion-Dollar Spinout?

CEO Corner

• Embracing Culture As A Strategic Business Asset

Companies To Watch

• Qlaris Bio

Industry Research

• Cell & Gene Therapy Outsourcing Process Development

Inside The Industry

• How Will The CGT Manufacturing Paradigm Mature In 2022?
• Overcoming Roadblocks Along The Cell Therapy Product Pathway
• Tackling Uncertainty In Drug R&D
• The Future Of Life Sciences Manufacturing And The Supply Chain
• 4 Tips For Advancing Your AAV Manufacturing Plans
• Reducing Human Error In GMP Operations With Defined Work Environments
• COVID Presents An Opportunity For Rural Biopharma Innovation
• Thanks To COVID, Your Culture May Need An Overhaul

Industry Leader

• The Trojan Horse Of Small Talk
• The Challenges — And Opportunities — Facing The European Biotech Industry

Leadership Lessons

• Why The Best Leaders Move Slowly

Ask The Board

• What Are A Few Of The Most Important Things A Startup CEO Needs To Do To Build A Strong Team And Culture?
• What Tips For Success Do You Have For A Mid-Level Manager When Transitioning Into Their First VP/C-Suite Position?
• What Tips For Success Do You Have For A Career Bench Scientist/Mid-Level Manager Transitioning Into Their First VP/C-Suite Position?